Nulojix
European approval for BMS kidney transplant drug Nulojix
June 22, 2011Sales and Marketing BMS, EMA, Nulojix, transplant
European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
